• Dual-action anti-diabetic formulation for effective blood glucose control.
• Contains Metformin Hydrochloride Prolonged-Release and Glimepiride.
• Helps improve insulin sensitivity and secretion.
• Designed for sustained and controlled release throughout the day.
• Supports long-term management of Type 2 diabetes.
• Convenient packaging: 10 strips of 15 tablets each.
• Suitable for adults under medical supervision.
• Promotes better glycemic balance alongside lifestyle changes.
• Prescription-only medication ensuring safe and regulated use.

GlimiSave M1 Tablets are a clinically trusted combination medication designed for the effective management of Type 2 diabetes mellitus. Manufactured by Eris Lifesciences, this advanced formulation combines Metformin Hydrochloride Prolonged-Release with Glimepiride, offering a dual mechanism of action that helps regulate blood glucose levels and supports metabolic health. It is commonly prescribed by healthcare professionals when diet, exercise, and single-drug therapy are insufficient to achieve optimal glycemic control.

Metformin Hydrochloride, a widely used biguanide, works primarily by decreasing glucose production in the liver and reducing intestinal absorption of glucose. It also enhances insulin sensitivity, enabling the body to utilize insulin more efficiently. The prolonged-release technology ensures gradual absorption of the medicine, providing consistent blood sugar control throughout the day while minimizing gastrointestinal discomfort often associated with conventional metformin formulations.

Glimepiride, a sulfonylurea class medication, complements metformin by stimulating the pancreas to release insulin. This helps maintain stable blood glucose levels, particularly after meals. Together, these two active ingredients deliver a synergistic effect, making GlimiSave M1 Tablets a reliable and effective solution for individuals living with Type 2 diabetes.

Regular use of GlimiSave M1 Tablets, as directed by a healthcare professional, supports improved glycemic control and reduces the risk of diabetes-related complications such as nerve damage, kidney issues, and cardiovascular disorders. However, the medication should always be taken as part of a comprehensive diabetes management plan that includes a balanced diet, regular exercise, and routine monitoring of blood glucose levels.

The prolonged-release formulation enhances patient convenience by reducing dosing frequency and ensuring sustained therapeutic action. This makes it particularly suitable for individuals seeking a manageable and effective treatment option. The tablets are packaged in secure blister packs to maintain their stability, potency, and hygiene.

GlimiSave M1 Tablets are intended exclusively for adults diagnosed with Type 2 diabetes mellitus. They are not suitable for treating Type 1 diabetes or diabetic ketoacidosis. Patients are advised to consult their healthcare provider before starting this medication, especially if they have underlying liver, kidney, or heart conditions.

Eris Lifesciences is renowned for its commitment to quality, innovation, and patient care. Manufactured under stringent pharmaceutical standards, GlimiSave M1 Tablets reflect the brand’s dedication to delivering safe and reliable healthcare solutions.

Disclaimer: This is a prescription-only medicine. It should be used strictly under the supervision of a qualified healthcare professional. The information provided here is for educational purposes only and should not substitute medical advice.

Active Ingredients:

Each tablet contains:

• Metformin Hydrochloride (Prolonged-Release).
• Glimepiride.

Refer to the product label or consult your doctor for exact strengths.

• Take the tablet exactly as prescribed by your doctor.
• Swallow whole with a glass of water.
• Do not crush, chew, or break the tablet.
• Usually taken with meals to reduce stomach discomfort.
• Take it at the same time each day for best results.
• Do not skip doses or discontinue without consulting your healthcare provider.

• Prescription-only medication; use under medical supervision.
• Not intended for Type 1 diabetes or diabetic ketoacidosis.
• Monitor blood glucose levels regularly.
• Inform your doctor about any kidney, liver, or heart conditions.
• Avoid excessive alcohol consumption while taking this medicine.
• Consult your doctor before use during pregnancy or breastfeeding.
• May cause low blood sugar; keep a quick source of glucose handy.
• Keep out of reach of children.
• Store in a cool, dry place away from direct sunlight.

Generic Name: Metformin Hydrochloride PR & Glimepiride Tablets.

Dosage Form: Oral Tablets.

Therapeutic Category: Anti-diabetic.

Prescription Required: Yes.

Storage: Store below 25°C in a cool and dry place.

Q1. What is GlimiSave M1 used for?
It is prescribed for the management of Type 2 diabetes mellitus.

Q2. Is GlimiSave M1 a prescription medicine?
Yes, it should be taken only with a doctor's prescription.

Q3. How does GlimiSave M1 work?
It combines Metformin and Glimepiride to help control blood sugar through complementary mechanisms.

Q4. Can this medicine be taken daily?
Yes, as directed by a healthcare professional.

Q5. Does GlimiSave M1 cause low blood sugar?
It may cause hypoglycemia, especially if meals are skipped or overdosed.

Q6. Can I take this medicine on an empty stomach?
It is generally recommended to take it with meals.

Q7. Is it suitable for Type 1 diabetes?
No, it is intended only for Type 2 diabetes.

Q8. Can alcohol be consumed while taking this medication?
Alcohol should be avoided unless approved by your doctor.

Q9. What should I do if I miss a dose?
Take it as soon as you remember unless it is close to the next dose. Do not double the dose.

Q10. How should GlimiSave M1 Tablets be stored?
Store in a cool, dry place below 25°C, away from direct sunlight and moisture.

Name: Eris Lifesciences Ltd.

Address: 8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India \ 7th Floor, Commerce House-4, Prahlad Nagar, Ahmedabad, Gujarat - 380015.